One important area we focus on is understanding GLP-1 and the medications that mimic its beneficial effects, such as Ozempic
2 Treatment for type 2 diabetes is initiated based on (glycated hemoglobin) HbA1C levels, treatment goals, and cardiovascular, renal, as well as hypoglycemia risk
People who prefer daily dosing over weekly injections
We have shown that expanded access to GLP-1s to treat obesity yields social returns of up to 20% annually for older populations
Patients have access to: Licensed U.S.-based physicians Injectable and oral GLP-1 options Ongoing provider support Flexible treatment approaches No insurance requirements Convenient home delivery The focus is always on safe, medically appropriate care tailored to the individual
GIP supplementation was also shown to be ineffective in the 1990s when intravenous (IV) GIP was introduced to hyperglycemic patients with no effect on their blood glucose though physiologic rather than pharmacologic concentrations were supplied [20]
![Wegovy Vision Loss Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/07/wegovy-blurred-vision.webp)
